Literature DB >> 19805540

Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis.

Michal Gutner1, Stella Chaushu, Daniela Balter, Gilad Bachrach.   

Abstract

Proteolysis is a common microbial virulence mechanism that enables the destruction of host tissue and evasion from host defense mechanisms. Antimicrobial peptides, also known as host defense peptides, are effector molecules of the innate immunity that demonstrate a broad range of antimicrobial and immunoregulatory activities. Deficiency of the human LL-37 antimicrobial peptide was previously correlated with severe periodontal disease. Porphyromonas gingivalis, the major pathogen associated with periodontitis, is highly proteolytic. In this study, P. gingivalis was found capable of degrading LL-37 by utilizing its arginine-specific gingipains. Saliva collected from volunteers with a healthy periodontium protected LL-37 from proteolysis by P. gingivalis. Salivary protection of LL-37 was heat resistant and specific and enabled LL-37 to inhibit growth of Escherichia coli in the presence of the P. gingivalis proteases. Previously, saliva and other body fluids have been shown to inhibit the antimicrobial activity of LL-37. Here we demonstrate that at a cost of a small reduction in the bactericidal activity of LL-37, saliva enables the antibacterial activity of LL-37 despite the presence of proteases secreted by the main periodontopathogen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19805540      PMCID: PMC2786438          DOI: 10.1128/IAI.00648-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

Review 1.  Defensins of vertebrate animals.

Authors:  Robert I Lehrer; Tomas Ganz
Journal:  Curr Opin Immunol       Date:  2002-02       Impact factor: 7.486

2.  The antimicrobial peptide LL-37 binds to the human plasma protein apolipoprotein A-I.

Authors:  Yuqin Wang; Jan Johansson; Birgitta Agerberth; Hans Jörnvall; William J Griffiths
Journal:  Rapid Commun Mass Spectrom       Date:  2004       Impact factor: 2.419

3.  Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study.

Authors:  Katrin Pütsep; Göran Carlsson; Hans G Boman; Mats Andersson
Journal:  Lancet       Date:  2002-10-12       Impact factor: 79.321

4.  Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence.

Authors:  Mohamed Zaiou; Victor Nizet; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2003-05       Impact factor: 8.551

5.  The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium.

Authors:  Johan D Heilborn; Margareta Frohm Nilsson; Gunnar Kratz; Günther Weber; Ole Sørensen; Niels Borregaard; Mona Ståhle-Bäckdahl
Journal:  J Invest Dermatol       Date:  2003-03       Impact factor: 8.551

6.  The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses.

Authors:  Monisha G Scott; Donald J Davidson; Michael R Gold; Dawn Bowdish; Robert E W Hancock
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

7.  Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein.

Authors:  J W Larrick; M Hirata; R F Balint; J Lee; J Zhong; S C Wright
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

8.  An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

Authors:  Rembert Koczulla; Georges von Degenfeld; Christian Kupatt; Florian Krötz; Stefan Zahler; Torsten Gloe; Katja Issbrücker; Pia Unterberger; Mohamed Zaiou; Corinna Lebherz; Alexander Karl; Philip Raake; Achim Pfosser; Peter Boekstegers; Ulrich Welsch; Pieter S Hiemstra; Claus Vogelmeier; Richard L Gallo; Matthias Clauss; Robert Bals
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

9.  A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release.

Authors:  Andreas Elssner; Michelle Duncan; Mikhail Gavrilin; Mark D Wewers
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

10.  Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense.

Authors:  De Yang; Arya Biragyn; David M Hoover; Jacek Lubkowski; Joost J Oppenheim
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

View more
  20 in total

1.  Mirolase, a novel subtilisin-like serine protease from the periodontopathogen Tannerella forsythia.

Authors:  Miroslaw Ksiazek; Abdulkarim Y Karim; Danuta Bryzek; Jan J Enghild; Ida B Thøgersen; Joanna Koziel; Jan Potempa
Journal:  Biol Chem       Date:  2015-03       Impact factor: 3.915

Review 2.  Antimicrobial peptides in periodontal innate defense.

Authors:  Sven-Ulrik Gorr
Journal:  Front Oral Biol       Date:  2011-11-11

3.  Actin enables the antimicrobial action of LL-37 peptide in the presence of microbial proteases.

Authors:  Asaf Sol; Yaniv Skvirsky; Rizan Nashef; Katya Zelentsova; Tal Burstyn-Cohen; Edna Blotnick; Andras Muhlrad; Gilad Bachrach
Journal:  J Biol Chem       Date:  2014-06-19       Impact factor: 5.157

4.  The Distinct Immune-Stimulatory Capacities of Porphyromonas gingivalis Strains 381 and ATCC 33277 Are Determined by the fimB Allele and Gingipain Activity.

Authors:  Stephen R Coats; Nutthapong Kantrong; Thao T To; Sumita Jain; Caroline A Genco; Jeffrey S McLean; Richard P Darveau
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

5.  The antibacterial activity of LL-37 against Treponema denticola is dentilisin protease independent and facilitated by the major outer sheath protein virulence factor.

Authors:  Graciela Rosen; Michael N Sela; Gilad Bachrach
Journal:  Infect Immun       Date:  2011-12-19       Impact factor: 3.441

6.  Are Hill's criteria for causality satisfied for vitamin D and periodontal disease?

Authors:  William B Grant; Barbara J Boucher
Journal:  Dermatoendocrinol       Date:  2010-01

7.  The Helicobacter pylori HopQ outermembrane protein inhibits immune cell activities.

Authors:  Chamutal Gur; Naseem Maalouf; Markus Gerhard; Bernhard B Singer; Johanna Emgård; Violeta Temper; Tzahi Neuman; Ofer Mandelboim; Gilad Bachrach
Journal:  Oncoimmunology       Date:  2019-01-29       Impact factor: 8.110

Review 8.  Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon's knife to a meat chopper-like brutal degradation of proteins.

Authors:  Yonghua Guo; Ky-Anh Nguyen; Jan Potempa
Journal:  Periodontol 2000       Date:  2010-10       Impact factor: 7.589

9.  Proteolytic effects of gingipains on trefoil factor family peptides.

Authors:  Ponlatham Chaiyarit; Janthima Jaresitthikunchai; Narumon Phaonakrop; Sittiruk Roytrakul; Barbara Potempa; Jan Potempa
Journal:  Clin Oral Investig       Date:  2017-07-19       Impact factor: 3.573

Review 10.  Polymicrobial synergy and dysbiosis in inflammatory disease.

Authors:  Richard J Lamont; George Hajishengallis
Journal:  Trends Mol Med       Date:  2014-11-20       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.